Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Sarepta Therapeutics buy BiotechBee

Sarepta Therapeutics
Start price
€16.10
29.10.23 / 50%
Target price
€150.00
31.03.26
Performance (%)
-
End price
-
30.10.23
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Sarepta Therapeutics 3.004% 3.004% -6.795%
iShares Core DAX® -1,59 % 5,03 % 6,33 %
iShares Nasdaq 100 -4,15 % -0,13 % 25,73 %
iShares Nikkei 225® -6,30 % 0,53 % 41,38 %
iShares S&P 500 -3,23 % 0,47 % 20,45 %

According to BiotechBee what are the pros and cons of Sarepta Therapeutics for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Sarepta Therapeutics diskutieren
Prediction Buy
Perf. (%) -
Target price 150.000
Change
Ends at 31.03.26

Buy mit Kursziel 150,0

BiotechBee 
0
Report Share
29.10.23
In the thread Trading Sarepta Therapeutics
Prediction Buy
Perf. (%) -
Target price 150.000
Change
Ends at 31.03.26

Buy beendet

BiotechBee 
0
Report Share
30.10.23